{
  "created_at": "Sat Aug 14 19:30:7 +0000 2021",
  "id_str": "1426357079397257221",
  "full_text": "Everyone is vying to be the next Moderna, whose market capitalisation has jumped from $5bn when it went public in late 2018 to $187bn now   https://t.co/3NoqsRkxVq",
  "display_text_range": [
    0,
    163
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/3NoqsRkxVq",
        "expanded_url": "https://econ.st/3gefjmT",
        "display_url": "econ.st/3gefjmT",
        "indices": [
          140,
          163
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 29,
  "favorite_count": 93,
  "possibly_sensitive": false,
  "original_created_at": "Sat Aug 14 01:36:42 +0000 2021"
}